查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1210922

霍亂疫苗全球市場規模和預測：按疫苗類型、副產品（Vaxchora、Dukoral、Shanchol、其他產品）、區域分析，2022-2029 年

Global Cholera Vaccines Market Size study & Forecast, by Vaccine Type (Whole cell V. cholerae O1 with Recombinant B-subunit, and Killed Oral O1, and O139), by Product (Vaxchora, Dukoral, Shanchol and Other Products) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球霍亂疫苗市場價值約為 8650 萬美元，預計在 2022-2029 年預測期內將以超過 8.2% 的健康增長率增長。

引起霍亂的霍亂弧菌通過攝入受污染的食物和水傳播。 受感染的個體會出現急性水樣腹瀉，最終導致脫水。 如果不及時治療，這種情況會導致脫水甚至死亡。 口服免疫療法已被證明是避免霍亂流行最有效的預防措施。 市場增長是由霍亂高發病率和霍亂控制工作數量增加等關鍵因素推動的。

由於多種因素，包括公共和私營部門活動增加、霍亂流行率上升以及全球對該病的認識提高，霍亂疫苗市場正在增長。 據世界衛生組織統計，2020年所有國家報告了1.3至140萬例霍亂病例，其中非洲17例，亞洲12例，歐洲4例，美洲4例。。 80% 的病例發生在海地、剛果民主共和國、越南、也門、秘魯、索馬裡和坦桑尼亞。 然而，疫苗的副作用阻礙了整個 2022-2029 年預測期內的市場增長。

全球霍亂疫苗市場研究考慮的主要區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於發病率高、意識增強和有效預防解決方案的可用性，亞太地區有記錄以來成為最大的地區。 然而，由於前往霍亂疫情國家的旅行增加以及疫苗接種需求增加，預計北美將成為增長最快的地區。

本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 本報告旨在捕捉被調查國家行業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年按全球市場和細分劃分的市場估計和預測
    • 霍亂疫苗市場：按地區劃分，2019-2029 年
    • 霍亂疫苗市場：按疫苗類型分類，2019-2029 年
    • 2019-2029 年各產品的霍亂疫苗市場
  • 主要趨勢
  • 調查方法介紹
  • 調查先決條件

第 2 章霍亂疫苗全球市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第三章霍亂疫苗全球市場動態

  • 霍亂疫苗市場影響分析 (2019-2029)
    • 市場驅動因素
      • 霍亂高發
      • 控制霍亂的更多舉措
    • 市場挑戰
      • 疫苗的副作用
    • 市場機會
      • 提高對霍亂預防醫學的認識
      • 全球霍亂疫苗的增加

第 4 章全球霍亂疫苗市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 頂級投資機會
  • 關鍵成功策略
  • 行業專家的展望
  • 分析師的結論和建議

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球霍亂疫苗市場，按疫苗類型分列

  • 市場概況
  • 全球霍亂疫苗市場：按疫苗類型進行性能潛力分析
  • 世界霍亂疫苗市場，按疫苗類型估算和預測（2019-2029 年）
  • 霍亂疫苗市場細分分析
    • 包含重組 B 亞基的全細胞霍亂弧菌 O1
    • 殺死 O1 和 O139

第 7 章：霍亂疫苗的全球市場：按產品分類

  • 市場概況
  • 全球霍亂疫苗市場：按產品、性能潛力分析
  • 2019-2029 年世界霍亂疫苗市場、按產品估算和預測
  • 霍亂疫苗市場細分分析
    • 巴克斯科拉
    • 雙珊瑚
    • 陳哲
    • 其他產品

第 8 章全球霍亂疫苗市場：區域分析

  • 霍亂疫苗市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年按疫苗類型估算和預測
      • 2019-2029 年按產品估算和預測
    • 加拿大
  • 歐洲霍亂疫苗市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區霍亂疫苗市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲的霍亂疫苗市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地方

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 田邊三菱製藥公司
      • 主要信息
      • 概覽
      • 財務信息（取決於數據可用性）
      • 產品概述
      • 近期趨勢
    • Takeda Pharmaceutical Co., Ltd.
    • AstraZeneca
    • GlaxoSmithKline plc（GSK）
    • Shantha Biotechnics Private Limited
    • Valneva SE
    • Astellas Pharma, Inc.
    • Emergent BioSolutions, Inc.
    • Pfizer, Inc.
    • Merck & Co., Inc.

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Cholera Vaccines Market is valued at approximately USD 86.5 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.2% over the forecast period 2022-2029. Vibrio cholera, which causes cholera, is spread by the intake of contaminated food or water. The infected people experience acute watery diarrhea, which eventually results in dehydration. If this condition is left untreated, the water loss might result in death. In order to avoid cholera epidemics, oral immunization has been found to be the most effective prophylactic measure. The market growth is driven by key players such as high incidence of cholera and rise in the number of initiatives to control cholera

The market for cholera vaccines is expanding as a result of several causes, including rising public and private sector activities, rising cholera prevalence, and increased global awareness of the disease. According to the World Health Organization, there were between 1.3 to 1.4 million cases of cholera reported in 2020 throughout all nations, including 17 in Africa, 12 in Asia, 4 in Europe, and 4 in the Americas. Eighty percent of all cases were in Haiti, the Demographic Republic of the Congo, Vietnam, Yemen, Peru, Somalia, and Tanzania. However, adverse effects of vaccines stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Cholera Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is recorded to be the largest region owing to high incidence rate, growing awareness, and availability of efficient preventive solutions. However, North America is expected to be the fastest growing region due to number of people traveling to countries with sudden outbreaks of cholera is increasing and demand for immunization is growing.

Major market players included in this report are:

Mitsubishi Tanabe Pharma Corporation

Takeda Pharmaceutical Co., Ltd.

AstraZeneca

GlaxoSmithKline plc (GSK)

Shantha Biotechnics Private Limited

Valneva SE

Astellas Pharma, Inc.

Emergent BioSolutions, Inc.

Pfizer, Inc.

Merck & Co., Inc.

Recent Developments in the Market:

  • In May 2022, more than 1.9 million children in Malawi are the target of a cholera immunisation campaign started by the World Health Organization Africa.
  • In June 2022, an oral cholera immunisation programme was started by the Ministry of Health and Partners in the Juba Country of Central Equatoria State. The campaign is a component of a plan of action to stop cholera outbreaks in the identified hotspot region.

Global Cholera Vaccines Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Vaccine type, Product, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Vaxchora

Dukoral

Shanchol

Other Products

By Vaccine Type:

Whole cell V. cholerae O1 with Recombinant B-subunit

Killed Oral O1 and O139

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Cholera Vaccine Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Cholera Vaccine Market, by Vaccine Type, 2019-2029 (USD Million)
    • 1.2.3. Cholera Vaccine Market, by Product, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cholera Vaccine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cholera Vaccine Market Dynamics

  • 3.1. Cholera Vaccine Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. High incidence of cholera
      • 3.1.1.2. Rise in the number of initiatives to control cholera
    • 3.1.2. Market Challenges
      • 3.1.2.1. Adverse effects of vaccines
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising awareness about cholera preventive care
      • 3.1.3.2. Rise in cholera vaccines across the world

Chapter 4. Global Cholera Vaccine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Cholera Vaccine Market, by Vaccine Type

  • 6.1. Market Snapshot
  • 6.2. Global Cholera Vaccine Market by Vaccine Type, Performance - Potential Analysis
  • 6.3. Global Cholera Vaccine Market Estimates & Forecasts by Vaccine Type 2019-2029 (USD Million)
  • 6.4. Cholera Vaccine Market, Sub Segment Analysis
    • 6.4.1. Whole cell V. cholerae O1 with Recombinant B-subunit
    • 6.4.2. Killed Oral O1 and O139

Chapter 7. Global Cholera Vaccine Market, by Product

  • 7.1. Market Snapshot
  • 7.2. Global Cholera Vaccine Market by Product, Performance - Potential Analysis
  • 7.3. Global Cholera Vaccine Market Estimates & Forecasts by Product 2019-2029 (USD Million)
  • 7.4. Cholera Vaccine Market, Sub Segment Analysis
    • 7.4.1. Vaxchora
    • 7.4.2. Dukoral
    • 7.4.3. Shanchol
    • 7.4.4. Other Products

Chapter 8. Global Cholera Vaccine Market, Regional Analysis

  • 8.1. Cholera Vaccine Market, Regional Market Snapshot
  • 8.2. North America Cholera Vaccine Market
    • 8.2.1. U.S. Cholera Vaccine Market
      • 8.2.1.1. Vaccine Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Product breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Cholera Vaccine Market
  • 8.3. Europe Cholera Vaccine Market Snapshot
    • 8.3.1. U.K. Cholera Vaccine Market
    • 8.3.2. Germany Cholera Vaccine Market
    • 8.3.3. France Cholera Vaccine Market
    • 8.3.4. Spain Cholera Vaccine Market
    • 8.3.5. Italy Cholera Vaccine Market
    • 8.3.6. Rest of Europe Cholera Vaccine Market
  • 8.4. Asia-Pacific Cholera Vaccine Market Snapshot
    • 8.4.1. China Cholera Vaccine Market
    • 8.4.2. India Cholera Vaccine Market
    • 8.4.3. Japan Cholera Vaccine Market
    • 8.4.4. Australia Cholera Vaccine Market
    • 8.4.5. South Korea Cholera Vaccine Market
    • 8.4.6. Rest of Asia Pacific Cholera Vaccine Market
  • 8.5. Latin America Cholera Vaccine Market Snapshot
    • 8.5.1. Brazil Cholera Vaccine Market
    • 8.5.2. Mexico Cholera Vaccine Market
    • 8.5.3. Rest of Latin America Cholera Vaccine Market
  • 8.6. Rest of The World Cholera Vaccine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Mitsubishi Tanabe Pharma Corporation
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Takeda Pharmaceutical Co., Ltd.
    • 9.2.3. AstraZeneca
    • 9.2.4. GlaxoSmithKline plc (GSK)
    • 9.2.5. Shantha Biotechnics Private Limited
    • 9.2.6. Valneva SE
    • 9.2.7. Astellas Pharma, Inc.
    • 9.2.8. Emergent BioSolutions, Inc.
    • 9.2.9. Pfizer, Inc.
    • 9.2.10. Merck & Co., Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Cholera Vaccine Market, report scope
  • TABLE 2. Global Cholera Vaccine Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Cholera Vaccine Market estimates & forecasts by Vaccine Type 2019-2029 (USD Million)
  • TABLE 4. Global Cholera Vaccine Market estimates & forecasts by Product 2019-2029 (USD Million)
  • TABLE 5. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 6. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Cholera Vaccine Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Cholera Vaccine Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. U.S. Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 17. U.S. Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. Canada Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 19. Canada Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. UK Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 22. UK Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. Germany Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 25. Germany Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. France Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 28. France Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. Italy Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 31. Italy Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Spain Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 34. Spain Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. RoE Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 37. RoE Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. China Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 40. China Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. India Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 43. India Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. Japan Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 46. Japan Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. South Korea Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 49. South Korea Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. Australia Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 52. Australia Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. RoAPAC Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. Brazil Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 58. Brazil Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Mexico Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 61. Mexico Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. RoLA Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 64. RoLA Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. Row Cholera Vaccine Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 67. Row Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Cholera Vaccine Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. List of secondary sources, used in the study of global Cholera Vaccine Market
  • TABLE 70. List of primary sources, used in the study of global Cholera Vaccine Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Cholera Vaccine Market, research methodology
  • FIG 2. Global Cholera Vaccine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Cholera Vaccine Market, key trends 2021
  • FIG 5. Global Cholera Vaccine Market, growth prospects 2022-2029
  • FIG 6. Global Cholera Vaccine Market, porters 5 force model
  • FIG 7. Global Cholera Vaccine Market, pest analysis
  • FIG 8. Global Cholera Vaccine Market, value chain analysis
  • FIG 9. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Cholera Vaccine Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Cholera Vaccine Market, regional snapshot 2019 & 2029
  • FIG 15. North America Cholera Vaccine Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Cholera Vaccine Market 2019 & 2029 (USD Million)
  • FIG 17. Asia Pacific Cholera Vaccine Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Cholera Vaccine Market 2019 & 2029 (USD Million)
  • FIG 19. Global Cholera Vaccine Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable